首頁 > 市場調查報告書 > 製藥

感染疾病

市場調查報告書

商品編碼

1729264

日本抗生素市場報告（按作用機制、藥物類別、活性範圍、給藥途徑、最終用戶和地區分類）2025-2033

Japan Antibiotics Market Report by Action Mechanism, Drug Class, Spectrum of Activity, Route of Administration, End User, and Region 2025-2033

出版日期: 2025年05月01日 | 出版商:

IMARC | 英文 118 Pages | 商品交期: 5-7個工作天內

價格

簡介目錄

2024 年，日本抗生素市場規模達 31.52 億美元。展望未來， IMARC Group預計到 2033 年市場規模將達到 58.51 億美元，2025-2033 年期間的成長率 (CAGR) 為 7.1%。傳染病的盛行率不斷上升，導致手術、醫療程序和住院治療，從而增加了對預防和治療此類疾病的抗生素的需求，這是推動市場發展的主要因素。

抗生素是用於治療細菌感染的強效藥物。它們透過瞄準並殺死細菌或抑制其生長來發揮作用。抗生素可分為幾類，每類都有其獨特的作用機轉。這些藥物都是由醫療保健專業人員在診斷出細菌感染後開出的。按照指示使用抗生素並完成規定的療程對於確保徹底消滅細菌至關重要。如果不這樣做，可能會導致抗生素抗藥性，即細菌對這些藥物的敏感性降低。雖然抗生素對細菌有效，但對普通感冒或流感等病毒感染無效。抗生素的過度使用或濫用引發了人們對抗生素抗藥性菌株發展的擔憂，因此必須謹慎使用抗生素，並且只在必要時才使用。為了對抗不斷演變的細菌威脅，對新型抗生素和替代療法的研究仍然是醫療保健領域關注的關鍵領域。

日本抗生素市場趨勢：

多年來，日本抗生素市場經歷了顯著成長，有幾個關鍵促進因素推動了這一上升趨勢。首先，細菌感染的增加必然導致抗生素需求的增加。此外，老年人口的增加（他們更容易受到感染）進一步加劇了這種需求。此外，生物技術方法的進步導致了新型抗生素的發現，從而擴大了市場。此外，抗生素抗藥性病原體的傳播使得對研發的投資變得緊迫，從而推動該領域的更多創新和發展。值得注意的是，政府和私人實體不斷增加的支持和資金對於推動研究計畫至關重要。另一個關鍵因素是人們對細菌感染及其影響的認知不斷提高，加上醫療設施的便利性。因此，抗生素處方量穩定成長，促進了市場發展。另一方面，儘管有效治療方案的必要性毋庸置疑，但人們擔心抗生素的過度使用可能會導致抗藥性。儘管如此，對有效抗菌治療的整體需求仍然至關重要，這些市場促進因素在塑造產業格局方面發揮著至關重要的作用。

日本抗生素市場區隔：

作用機制洞察：

細胞壁合成抑制劑
蛋白質合成抑制劑
DNA合成抑制劑
RNA合成抑制劑
肌酸抑制劑
其他

藥物類別洞察：

頭孢菌素
青黴素
氟喹諾酮類藥物
大環內酯類
卡巴培南
氨基糖苷類
其他

活動洞察範圍：

廣效抗生素
窄譜抗生素

給藥途徑洞察：

口服
腸外
外用
其他

最終用戶洞察：

醫院
專科診所
其他

競爭格局：

市場研究報告也對競爭格局進行了全面的分析。報告涵蓋了市場結構、關鍵參與者定位、最佳制勝策略、競爭儀表板和公司評估象限等競爭分析。此外，也提供了所有主要公司的詳細資料。

本報告回答的關鍵問題：

日本抗生素市場迄今表現如何？未來幾年將如何表現？
COVID-19 對日本抗生素市場有何影響？
日本抗生素市場依作用機制如何分類？
日本抗生素市場依藥品類別如何分類？
根據活動範圍，日本抗生素市場是如何分類的？
根據給藥途徑，日本抗生素市場是如何分類的？
根據最終用戶，日本抗生素市場的分佈是怎樣的？
日本抗生素市場的價值鏈分為哪些階段？
日本抗生素的關鍵促進因素和挑戰是什麼？
日本抗生素市場的結構是怎麼樣的？主要參與者是誰？
日本抗生素市場的競爭程度如何？

本報告回答的關鍵問題：

日本抗生素市場迄今表現如何？未來幾年將如何表現？
COVID-19 對日本抗生素市場有何影響？
日本抗生素市場依作用機制如何分類？
日本抗生素市場依藥品類別如何分類？
根據活動範圍，日本抗生素市場是如何分類的？
根據給藥途徑，日本抗生素市場是如何分類的？
根據最終用戶，日本抗生素市場的分佈是怎樣的？
日本抗生素市場的價值鏈分為哪些階段？
日本抗生素的關鍵促進因素和挑戰是什麼？
日本抗生素市場的結構是怎麼樣的？主要參與者是誰？
日本抗生素市場的競爭程度如何？

Japan antibiotics market size reached USD 3,152 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 5,851 Million by 2033, exhibiting a growth rate (CAGR) of 7.1% during 2025-2033. The escalating prevalence of infectious diseases, which also leads to surgeries, medical procedures, and hospitalizations, thereby increasing the need for antibiotics to prevent and treat such conditions, is primarily driving the market.

Antibiotics are powerful medications used to treat bacterial infections. They work by targeting and killing bacteria or inhibiting their growth. Antibiotics can be categorized into several classes, each with its unique mechanism of action. They are prescribed by healthcare professionals after diagnosing a bacterial infection. It's crucial to use antibiotics as directed and complete the prescribed course to ensure the complete eradication of bacteria. Failure to do so can lead to antibiotic resistance, where bacteria become less responsive to these drugs. While antibiotics are effective against bacteria, they do not work on viral infections like the common cold or flu. Overuse or misuse of antibiotics has raised concerns about the development of antibiotic-resistant strains of bacteria, making it essential to use them judiciously and only when necessary. Research into new antibiotics and alternative treatments continues to be a critical area of focus in healthcare to combat evolving bacterial threats.

Japan Antibiotics Market Trends:

The antibiotics market in Japan has witnessed significant growth over the years, and several key drivers have propelled this upward trajectory. Firstly, the rise in bacterial infections has necessitated an increased demand for antibiotics. Additionally, the expansion of the geriatric population, which is more susceptible to infections, has further fueled this need. Moreover, advancements in biotechnological methods have led to the discovery of novel antibiotics, thus expanding the market. Furthermore, the spread of antibiotic-resistant pathogens has created an urgency to invest in R&D, leading to more innovations and developments in the sector. Notably, the increasing support and funding from both government and private entities have been pivotal in pushing forward research initiatives. Another crucial factor is the growing awareness among people about bacterial infections and their implications, coupled with easy access to healthcare facilities. Consequently, there is a steady growth in antibiotic prescriptions, boosting the market. On the other hand, though the need for effective treatment regimens is undeniable, there are concerns about antibiotic overuse, potentially causing resistance. Nevertheless, the overall need for effective antibacterial treatments remains paramount, and these market drivers play a crucial role in shaping the industry's landscape.

Japan Antibiotics Market Segmentation:

Action Mechanism Insights:

Cell Wall Synthesis Inhibitors
Protein Synthesis Inhibitors
DNA Synthesis Inhibitors
RNA Synthesis Inhibitors
Mycolic Acid Inhibitors
Others

Drug Class Insights:

Cephalosporin
Penicillin
Fluoroquinolone
Macrolide
Carbapenem
Aminoglycoside
Others

Spectrum of Activity Insights:

Broad-Spectrum Antibiotics
Narrow-Spectrum Antibiotics

Route of Administration Insights:

Oral
Parenteral
Topical
Others

End User Insights:

Hospitals
Specialty Clinics
Others

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

How has the Japan antibiotics market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the Japan antibiotics market?
What is the breakup of the Japan antibiotics market on the basis of action mechanism?
What is the breakup of the Japan antibiotics market on the basis of drug class?
What is the breakup of the Japan antibiotics market on the basis of spectrum of activity?
What is the breakup of the Japan antibiotics market on the basis of route of administration?
What is the breakup of the Japan antibiotics market on the basis of end user?
What are the various stages in the value chain of the Japan antibiotics market?
What are the key driving factors and challenges in the Japan antibiotics?
What is the structure of the Japan antibiotics market and who are the key players?
What is the degree of competition in the Japan antibiotics market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Japan Antibiotics Market - Introduction

4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence

5 Japan Antibiotics Market Landscape

5.1 Historical and Current Market Trends (2019-2024)
5.2 Market Forecast (2025-2033)

6 Japan Antibiotics Market - Breakup by Action Mechanism

6.1 Cell Wall Synthesis Inhibitors
- 6.1.1 Overview
- 6.1.2 Historical and Current Market Trends (2019-2024)
- 6.1.3 Market Forecast (2025-2033)
6.2 Protein Synthesis Inhibitors
- 6.2.1 Overview
- 6.2.2 Historical and Current Market Trends (2019-2024)
- 6.2.3 Market Forecast (2025-2033)
6.3 DNA Synthesis Inhibitors
- 6.3.1 Overview
- 6.3.2 Historical and Current Market Trends (2019-2024)
- 6.3.3 Market Forecast (2025-2033)
6.4 RNA Synthesis Inhibitors
- 6.4.1 Overview
- 6.4.2 Historical and Current Market Trends (2019-2024)
- 6.4.3 Market Forecast (2025-2033)
6.5 Mycolic Acid Inhibitors
- 6.5.1 Overview
- 6.5.2 Historical and Current Market Trends (2019-2024)
- 6.5.3 Market Forecast (2025-2033)
6.6 Others
- 6.6.1 Historical and Current Market Trends (2019-2024)
- 6.6.2 Market Forecast (2025-2033)

7 Japan Antibiotics Market - Breakup by Drug Class

7.1 Cephalosporin
- 7.1.1 Overview
- 7.1.2 Historical and Current Market Trends (2019-2024)
- 7.1.3 Market Forecast (2025-2033)
7.2 Penicillin
- 7.2.1 Overview
- 7.2.2 Historical and Current Market Trends (2019-2024)
- 7.2.3 Market Forecast (2025-2033)
7.3 Fluoroquinolone
- 7.3.1 Overview
- 7.3.2 Historical and Current Market Trends (2019-2024)
- 7.3.3 Market Forecast (2025-2033)
7.4 Macrolide
- 7.4.1 Overview
- 7.4.2 Historical and Current Market Trends (2019-2024)
- 7.4.3 Market Forecast (2025-2033)
7.5 Carbapenem
- 7.5.1 Overview
- 7.5.2 Historical and Current Market Trends (2019-2024)
- 7.5.3 Market Forecast (2025-2033)
7.6 Aminoglycoside
- 7.6.1 Overview
- 7.6.2 Historical and Current Market Trends (2019-2024)
- 7.6.3 Market Forecast (2025-2033)
7.7 Others
- 7.7.1 Historical and Current Market Trends (2019-2024)
- 7.7.2 Market Forecast (2025-2033)

8 Japan Antibiotics Market - Breakup by Spectrum of Activity

8.1 Broad-Spectrum Antibiotics
- 8.1.1 Overview
- 8.1.2 Historical and Current Market Trends (2019-2024)
- 8.1.3 Market Forecast (2025-2033)
8.2 Narrow-Spectrum Antibiotics
- 8.2.1 Overview
- 8.2.2 Historical and Current Market Trends (2019-2024)
- 8.2.3 Market Forecast (2025-2033)

9 Japan Antibiotics Market - Breakup by Route of Administration

9.1 Oral
- 9.1.1 Overview
- 9.1.2 Historical and Current Market Trends (2019-2024)
- 9.1.3 Market Forecast (2025-2033)
9.2 Parenteral
- 9.2.1 Overview
- 9.2.2 Historical and Current Market Trends (2019-2024)
- 9.2.3 Market Forecast (2025-2033)
9.3 Topical
- 9.3.1 Overview
- 9.3.2 Historical and Current Market Trends (2019-2024)
- 9.3.3 Market Forecast (2025-2033)
9.4 Others
- 9.4.1 Historical and Current Market Trends (2019-2024)
- 9.4.2 Market Forecast (2025-2033)

10 Japan Antibiotics Market - Breakup by End User

10.1 Hospitals
- 10.1.1 Overview
- 10.1.2 Historical and Current Market Trends (2019-2024)
- 10.1.3 Market Forecast (2025-2033)
10.2 Specialty Clinics
- 10.2.1 Overview
- 10.2.2 Historical and Current Market Trends (2019-2024)
- 10.2.3 Market Forecast (2025-2033)
10.3 Others
- 10.3.1 Historical and Current Market Trends (2019-2024)
- 10.3.2 Market Forecast (2025-2033)

11 Japan Antibiotics Market - Competitive Landscape

11.1 Overview
11.2 Market Structure
11.3 Market Player Positioning
11.4 Top Winning Strategies
11.5 Competitive Dashboard
11.6 Company Evaluation Quadrant

12 Profiles of Key Players

12.1 Company A
- 12.1.1 Business Overview
- 12.1.2 Product Portfolio
- 12.1.3 Business Strategies
- 12.1.4 SWOT Analysis
- 12.1.5 Major News and Events
12.2 Company B
- 12.2.1 Business Overview
- 12.2.2 Product Portfolio
- 12.2.3 Business Strategies
- 12.2.4 SWOT Analysis
- 12.2.5 Major News and Events
12.3 Company C
- 12.3.1 Business Overview
- 12.3.2 Product Portfolio
- 12.3.3 Business Strategies
- 12.3.4 SWOT Analysis
- 12.3.5 Major News and Events
12.4 Company D
- 12.4.1 Business Overview
- 12.4.2 Product Portfolio
- 12.4.3 Business Strategies
- 12.4.4 SWOT Analysis
- 12.4.5 Major News and Events
12.5 Company E
- 12.5.1 Business Overview
- 12.5.2 Product Portfolio
- 12.5.3 Business Strategies
- 12.5.4 SWOT Analysis
- 12.5.5 Major News and Events

13 Japan Antibiotics Market - Industry Analysis

13.1 Drivers, Restraints and Opportunities
- 13.1.1 Overview
- 13.1.2 Drivers
- 13.1.3 Restraints
- 13.1.4 Opportunities
13.2 Porters Five Forces Analysis
- 13.2.1 Overview
- 13.2.2 Bargaining Power of Buyers
- 13.2.3 Bargaining Power of Suppliers
- 13.2.4 Degree of Competition
- 13.2.5 Threat of New Entrants
- 13.2.6 Threat of Substitutes
13.3 Value Chain Analysis